• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dose escalation in lung cancer: have we gone full circle?

作者信息

Faivre-Finn Corinne

机构信息

Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.

出版信息

Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X. Epub 2015 Jan 16.

DOI:10.1016/S1470-2045(15)70001-X
PMID:25601340
Abstract
摘要

相似文献

1
Dose escalation in lung cancer: have we gone full circle?肺癌中的剂量递增：我们是否已回到原点？
Lancet Oncol. 2015 Feb;16(2):125-7. doi: 10.1016/S1470-2045(15)70001-X. Epub 2015 Jan 16.
2
Radiotherapy dose and fractionation for stage III NSCLC.III期非小细胞肺癌的放射治疗剂量与分割
Lancet Oncol. 2015 Apr;16(4):e156-7. doi: 10.1016/S1470-2045(15)70121-X.
3
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.标准剂量与高剂量适形放疗联合并巩固使用卡铂加紫杉醇，联合或不联合西妥昔单抗治疗IIIA期或IIIB期非小细胞肺癌患者（RTOG 0617）：一项随机、二乘二析因3期研究。
Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16.
4
Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).同步化疗与递增剂量放疗治疗不可切除非小细胞肺癌试验的长期结果：NCCTG N0028（联盟研究）
J Thorac Oncol. 2017 Apr;12(4):697-703. doi: 10.1016/j.jtho.2016.12.021. Epub 2017 Jan 12.
5
Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer.局部晚期非小细胞肺癌高剂量与标准剂量根治性放化疗的配对分析
Clin Lung Cancer. 2017 Mar;18(2):149-155. doi: 10.1016/j.cllc.2016.06.004. Epub 2016 Jun 23.
6
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer.培美曲塞联合卡铂，或培美曲塞联合顺铂同步放疗后序贯培美曲塞巩固治疗对预后良好的不可切除IIIA/B期非小细胞肺癌患者的2期研究。
J Thorac Oncol. 2013 Oct;8(10):1308-16. doi: 10.1097/JTO.0b013e3182a02546.
7
Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.顺铂联合培美曲塞或长春瑞滨加同期晚期加速超分割放疗用于不可切除的Ⅲ期非小细胞肺癌患者的Ⅲ期研究
Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871.
8
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.质子治疗联合化疗治疗非小细胞肺癌：技术和早期结果。
Clin Lung Cancer. 2012 Sep;13(5):352-8. doi: 10.1016/j.cllc.2011.11.008. Epub 2012 Jan 20.
9
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.三维适形胸部放疗联合同步顺铂和 S-1 治疗不可手术 III 期非小细胞肺癌的剂量递增研究。
Clin Lung Cancer. 2013 Jul;14(4):440-5. doi: 10.1016/j.cllc.2013.01.003. Epub 2013 Mar 27.
10
Evolution of a Lung-Sparing Strategy with Sleeve Lobectomy and Induction Therapy for Non-small Cell Lung Cancer: 20-Year Experience at a Single Institution.采用袖式肺叶切除术和诱导治疗的非小细胞肺癌肺保留策略的演变：单机构20年经验
World J Surg. 2016 Apr;40(4):906-12. doi: 10.1007/s00268-015-3330-z.

引用本文的文献

1
Enhanced cardiac substructure sparing through knowledge-based treatment planning for non-small cell lung cancer radiotherapy.通过基于知识的非小细胞肺癌放疗治疗计划实现增强的心脏亚结构保留
Front Oncol. 2022 Dec 2;12:1055428. doi: 10.3389/fonc.2022.1055428. eCollection 2022.
2
Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.放化疗联合或不联合巩固 durvalumab 治疗 III 期非小细胞肺癌的复发模式和无进展生存期。
J Radiat Res. 2023 Jan 20;64(1):142-153. doi: 10.1093/jrr/rrac057.
3
Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials.
序贯或同步化疗联合低分割放疗治疗局部晚期非小细胞肺癌：一项随机试验的荟萃分析
J Thorac Dis. 2021 Nov;13(11):6272-6282. doi: 10.21037/jtd-21-573.
4
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer.非小细胞肺癌放射治疗中的剂量与分割方案
Transl Lung Cancer Res. 2021 Apr;10(4):1969-1982. doi: 10.21037/tlcr-20-253.
5
Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.III期非小细胞肺癌的等毒性调强放射治疗：一项可行性研究。
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1341-1348. doi: 10.1016/j.ijrobp.2020.11.040. Epub 2020 Nov 21.
6
Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer.局部晚期非小细胞肺癌中心血管系统的剂量及治疗引起的心电图异常
Clin Transl Radiat Oncol. 2019 Sep 21;19:96-102. doi: 10.1016/j.ctro.2019.09.003. eCollection 2019 Nov.
7
The evolving role of radiotherapy in non-small cell lung cancer.放疗在非小细胞肺癌中的作用演变。
Br J Radiol. 2019 Dec;92(1104):20190524. doi: 10.1259/bjr.20190524. Epub 2019 Sep 19.
8
Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.质子与光子：基于模型的局部晚期肺癌患者心脏毒性降低的选择方法。
Radiother Oncol. 2020 Nov;152:151-162. doi: 10.1016/j.radonc.2019.06.032. Epub 2019 Aug 17.
9
Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.循环 microRNAs 作为非小细胞肺癌放射性心脏毒性的生物标志物。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1635-1643. doi: 10.1007/s00432-019-02903-5. Epub 2019 Mar 28.
10
Rationale and early outcomes for the management of thymoma with proton therapy.胸腺瘤质子治疗的原理及早期疗效
Transl Lung Cancer Res. 2018 Apr;7(2):106-113. doi: 10.21037/tlcr.2018.04.06.